UNSPSC 51295105: Clodazon hydrochloride

This classification denotes an antidepressant agent with the molecular formula C18H20ClN3O.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FSF9L5AH4G, chemically known as 2h-benzimidazol-2-one, 5-chloro-1(3-(dimethylamino)propyl)-1,3-dihydro-3-phenyl-, monohydrochloride, monohydrate but more generally known as clodazon hydrochloride, which bears US NIH Compound Identifier 167451. Most nations, for tariff and trade purposes, schedule clodazon hydrochloride under HS 29339990 and SITC 51577.

As of Q4 2014, CLODAZON HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Clodazon hydrochloride bears US NLM identifiers UMLS ID C2699360 and NCI Concept Code C78012. SMILES: CN(C)CCCN1C2CCC(CC2N(C1=O)C3CCCCC3)CL.O.CL.

UNSPSC 51295105 Clodazon hydrochloride (Commodity) shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits Naloxone and Safe Drug Deactivation Systems, which represent a material mismatch with the code's pharmaceutical classification. The opportunity does not describe acquisition of clodazon hydrochloride or any related pharmaceutical compound, and the county's procurement focus on opioid-reversal and drug-deactivation equipment falls outside the code's intended product family. State and local procurement offices appear to use this code infrequently or inconsistently for pharmaceutical acquisitions.

Seminole County posted the Naloxone and Drug Deactivation Systems IFB on June 30, 2026, with a response deadline of July 26, 2023 (the posted and due dates do not align, indicating a data inconsistency in the source). The county sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement included standard state and local compliance requirements—drug-free workplace certification, E-Verify verification, workers' compensation and general liability insurance, and a three-month probationary termination clause—and carried an initial two-year term with one-year renewal option. The contract may draw FEMA funding, introducing federal compliance obligations including Clean Air Act and Federal Water Pollution Control Act adherence. The mismatch between the UNSPSC code's pharmaceutical scope and the actual solicitation suggests that pursuing opportunities under this code requires verification of whether posted requirements align with clodazon hydrochloride or related pharmaceutical products.